Analysts' Actions: CXO FIO MPC NOV SFM

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Concho was initiated with a hold rating at Canaccord Genuity. Valuation call, based on a $100 price target, Canaccord Genuity said.

First Horizon was downgraded at Wunderlich to hold from buy. $11 price target. Company is facing headwinds in spread-based banking and fixed-income sales, Wunderlich said.

Fusion-io was upgraded at Piper Jaffray to overweight. $17 price target. PCIe flash market is rapidly expanding, Piper Jaffray said.

Legg Mason was downgraded to hold at TheStreet Ratings.

Masco was upgraded at Oppenheimer to outperform from perform. $25 price target. Company should continue to benefit from a stronger domestic housing market, Oppenheimer said.

Marathon Petroleum was downgraded at Credit Suisse to neutral from outperform. Refining capture remains low, Credit Suisse said.

Marvell Technology was upgraded to overweight from neutral at J.P. Morgan. $16 price target. Improved execution and expanding revenue/earnings growth profile, J.P. Morgan said.

National Oilwell Varco was upgraded at Credit Suisse to outperform from neutral. $90 price target. Increased confidence in the company's orders and rig technology margins, Credit Suisse said.

Sprouts Farmers Market was initiated with a neutral rating and $39 price target at UBS. SFM is well-positioned as a low-priced organic grocer, UBS said.

Sprouts was initiated with a neutral rating at Goldman Sachs. Valuation call, based on a $33 price target.

Sprout was initiated with an underperform rating at Bank of America/Merrill Lynch. $37 price target. Valuation call, as the stock has already doubled since its IPO, BofA/Merrill said.

TC Pipelines LP was downgraded to hold at TheStreet Ratings.

STOCK COMMENTS / EPS CHANGES

Five Below earnings estimates were raised at UBS based on the second-quarter beat and potential upside from the rubber band bracelet craze. Price target goes to $50.

Five Below numbers were raised at Credit Suisse. Shares are now seen reaching $46. Estimates were also increased, as the company is executing well in new markets, Credit Suisse said. Neutral rating.

Five Below numbers were raised at Jefferies. Shares are now seen reaching $51. Estimates also increased on strong quarterly results despite tougher seasonal sales, Jefferies said. Buy rating.

Haemonetics estimates, price target were boosted at Benchmark. Shares are now seen reaching $49. New analyst also raised estimates, as the company has premium pricing power, Benchmark said. Buy rating.

Las Vegas Sands price target was raised at J.P. Morgan to $72. Multiple positive near-term and longer-term catalysts, J.P. Morgan said. Overweight rating.

Merck estimates were increased at BMO Capital through 2014. Company has a solid pipeline, and Januvia can continue to growth, BMO Capital said. Market Perform rating and $50 price target.

M&T Bank numbers were cut at BMO Capital. Shares are now seen reaching $121. Estimates were also reduced, given the company's new guidance, BMO Capital said. Market Perform rating.

Noble estimates were raised at UBS. Reflect five new jackup contracts, said UBS. Price target is $41.

Oasis Petroleum numbers were increased at Sterne Agee. Estimates were boosted through 2015. Recent acquisition should add to earnings, Sterne Agee said. Buy rating and new $54 price target.

Palo Alto numbers were raised at BMO Capital. Shares are now seen reaching $50. Estimates were also increased, given better license and billings growth, BMO Capital said. Market Perform rating.

Raytheon estimates, price target were increased at Jefferies. Estimates were raised through 2014. Company is gaining market share and can continue to grow overseas, Jefferies said. Buy rating and new $87 price target.

Zoetis was added to the US 1 List at Bank of America/Merrill Lynch. Profit margin acceleration story is underappreciated by the market, BofA/Merrill said. $36 price target.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

Rates

View Comments (0)